PACB - Pacific Biosciences of California, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue90,71492,78260,594
Cost of Revenue46,55439,33237,192
Gross Profit44,16053,45023,402
Operating Expenses
Research Development67,61760,44048,230
Selling General and Administrative47,78722,14438,026
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-71,244-29,134-62,854
Income from Continuing Operations
Total Other Income/Expenses Net103364-478
Earnings Before Interest and Taxes-71,141-28,770-63,332
Interest Expense3,2342,9262,828
Income Before Tax-74,375-31,696-66,160
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-74,375-31,696-66,160
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-74,375-31,696-66,160
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-74,375-31,696-66,160